Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
There is increasing evidence that apoptotic and necrotic hepatocyte death following endotoxin‐induced liver injury act as signals for leukocyte sequestration in the liver vasculature. p53 has been implicated to promote apoptosis through trans ‐activation and down‐regulation of specific pro‐ and anti‐apoptotic genes. Here, we report that inhibition of p53 decreases apoptotic and necrotic tissue injury as well as inflammatory cell response. Sprague‐Dawley rats were injected intraperitoneally with 2.2 mg/kg pifithrin‐α (PFT), a p53‐inactivating agent, or the vehicle DMSO 30 min before intravenous exposure to lipopolysaccharide (LPS). In vehicle‐pretreated animals, LPS induced significant apoptosis and necrosis of hepatocytes, which was associated with intrahepatic leukocyte recruitment, microvascular dysfunction, and enzyme release. Inhibition of p53 effectively attenuated ( P <0.05) hepatocellular apoptosis and necrosis, but also reduced leukocyte recruitment and microvascular dysfunction. Western blot analysis revealed that PFT lowered the nuclear‐to‐cytoplasmic p53 ratio and reduced both activation of NF‐κB and cleavage of procaspase 3 ( P< 0.05). In parallel, immunohistochemistry of PFT‐pretreated, but not vehicle‐pretreated, endotoxic animals exhibited nuclear p53 exclusion and reduced NF‐κB p65 staining. This indicates that p53 mediates, at least in part, LPS‐associated apoptosis and contributes to inflammatory endotoxic tissue injury through leukocyte activation and intraorgan sequestration.—Schäfer, T., Scheuer, C., Roemer, K., Menger, M. D., Vollmar, B. Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Yin, X.-M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., & Korsmeyer, S. J. (1999) · Nature · doi:10.1038/23730 · Cited by 1,004 · cited 2×
“On the other hand, there is evidence for TNF- - independent mechanisms of induction of hepatocellular apoptosis, including the Fas-FasL-system (7, 11, 12) and TRAIL (13).”
Cited by
Vollmar, B., & Menger, M. D. (2009) · Physiological Reviews · doi:10.1152/physrev.00027.2008 · Cited by 500
Self-citationCross talk between stimulated NF-κB and the tumor suppressor p53
Schneider, G., Henrich, A., Greiner, G., Wolf, V, Lovas, A., Wieczorek, M., Wagner, T., Reichardt, S., von Werder, A., Schmid, R. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.46 · Cited by 149
Tomita, K., Teratani, T., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Nishiyama, K., Mataki, N., Irie, R., Minamino, T., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.013 · Cited by 127
Metadata
- Authors
- Schäfer, T., Scheuer, C., Roemer, K., Menger, M. D., & Vollmar, B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 17
- Issue
- 6
- Pages
- 660-667
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1974383277
- Cited by
- 104
- References
- 2
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death. https://app.cochat.ai/papers/10.1096/fj.02-0774com
- The paper
- Schäfer, T., Scheuer, C., Roemer, K., Menger, M. D., & Vollmar, B. (2003). Inhibition of p53 protects liver tissue against endotoxin‐induced apoptotic and necrotic cell death. The FASEB Journal. https://doi.org/10.1096/fj.02-0774com
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.